Coupang financials
$13.85+0.73%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $34.53B | $30.27B | $24.38B | $20.58B | $18.41B |
| Gross profit | $10.14B | $8.83B | $6.19B | $4.71B | $2.95B |
| Gross margin | 29.4% | 29.2% | 25.4% | 22.9% | 16.0% |
| Operating income | $473.0M | $436.0M | $473.0M | -$112.0M | -$1.49B |
| Net income | $208.0M | $154.0M | $1.36B | -$92.0M | -$1.54B |
| Net margin | 0.6% | 0.5% | 5.6% | −0.4% | −8.4% |
| Diluted EPS | $0.11 | $0.08 | $0.75 | $-0.05 | $-1.08 |
| EBITDA | $990.0M | $869.0M | $748.0M | $119.0M | -$1.03B |
| Operating cash flow | $1.77B | $1.89B | $2.65B | $565.0M | -$411.0M |
| Free cash flow | $522.0M | $1.01B | $1.76B | -$259.0M | -$1.08B |
| Diluted shares | 1,855.0M | 1,826.0M | 1,803.0M | 1,765.0M | 1,424.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $6.32B | $5.88B | $5.24B | $3.51B | $3.49B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Total debt | $1.61B | $1.53B | $1.01B | $842.0M | $632.7M |
| Total assets | $17.79B | $15.34B | $13.35B | $9.51B | $8.64B |
| Total liabilities | $13.16B | $11.17B | $9.24B | $7.10B | $6.47B |
| Shareholders' equity | $4.62B | $4.10B | $4.09B | $2.41B | $2.18B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology